Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions

NCT00625521 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Discoid Lupus Erythematosus

Interventions

DRUG: ASF 1096 0.5 % cream applied twice daily
DRUG: Cream vehicle for ASF 1096 cream applied twice daily

Sponsor

Astion Pharma A/S